Produced by Araxis Merge on 3/30/2018 9:10:30 AM Central Daylight Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
# | Location | File | Last Modified |
---|---|---|---|
1 | CAS_RxSU2_Build-2_Sprint-1.zip\CAS_RxSU2_Build-2_Sprint-1_Documentation\CAS_RxSU2_Build_2_Sprint-1_Test_Cases | CAS_Test_Case_RxSU2_TC_001.docx | Fri Mar 9 14:43:23 2018 UTC |
2 | CAS_RxSU2_Build-2_Sprint-1.zip\CAS_RxSU2_Build-2_Sprint-1_Documentation\CAS_RxSU2_Build_2_Sprint-1_Test_Cases | CAS_Test_Case_RxSU2_TC_001.docx | Thu Mar 29 21:31:56 2018 UTC |
Description | Between Files 1 and 2 |
|
---|---|---|
Text Blocks | Lines | |
Unchanged | 1 | 682 |
Changed | 0 | 0 |
Inserted | 0 | 0 |
Removed | 0 | 0 |
Whitespace | |
---|---|
Character case | Differences in character case are significant |
Line endings | Differences in line endings (CR and LF characters) are ignored |
CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
1 | Option | |
2 | ||
3 | Department of Vetera ns Affairs | |
4 | ||
5 | Clinical A ncillary S ervices (C AS) | |
6 | ||
7 | ||
8 | Sprint-1 | |
9 | Test Case CAS_RxSU2_ TC_001 | |
10 | ||
11 | CLIN# 2004 AE | |
12 | February 2 018 | |
13 | Version 1. 0 | |
14 | Revision H istory | |
15 | Date | |
16 | Version | |
17 | Descriptio n | |
18 | Author | |
19 | 02/15/2018 | |
20 | 1.0 | |
21 | Accept Non -VA Medica tion with complex si g | |
22 | Samuel Gut ema | |
23 | ||
24 | Table of C ontents | |
25 | 1Product D escription 1 | |
26 | 1.1Purpose 1 | |
27 | 1.2Scope1 | |
28 | 2Test Case 1 | |
29 | Appendix A .Acronyms & Abbrevia tions5 | |
30 | ||
31 | ||
32 | Product De scription | |
33 | OneVA Phar macy Clini cal Ancill ary Servic es (CAS) p roject | |
34 | Purpose | |
35 | The purpos e of this document i s to devel op test ca se scenari os to iden tify, clar ify, and o rganize CA S applicat ion requir ements. Th e test cas e is made up of a se t of possi ble sequen ces of int eractions between sy stems and users in t he CHYSHR, DAYTSHR a nd CPRS en vironments to valida te as a cl inician en tering non -VA medica tions, use r need the option to use the “ Complex” S IG functio nality (av ailable fo r outpatie nt medicat ions), so that I can capture v ariations in medicat ion schedu les | |
36 | The CHYSHR environme nt is the Host site. The DAYT SHR enviro nment is t he dispens ing site ( remote). | |
37 | The test c ase should contain a ll system activities that have significa nce to the Pharmacis t users. | |
38 | Scope | |
39 | As a clini cian enter ing non-VA medicatio ns, user n eed the op tion to us e the “Com plex” SIG functional ity (avail able for o utpatient medication s), so tha t I can ca pture vari ations in medication schedules | |
40 | Test Case | |
41 | CAS Test C ases and s upporting test scrip ts will be recorded managed in VA Enterp rise Jazz Rational Q uality Man ager Tool PBM(QM). Stakehold ers can al so provide inputs ab out the cu rrent set of test ca ses as wel l as sugge st some mo re missing test case s. | |
42 | This test case will: | |
43 | Capture an d communic ate functi onal requi rements fo r software developme nt; and | |
44 | Provide a set of tes t inputs, execution conditions , and expe cted resul ts develop ed for a p articular objective, such as t o exercise a particu lar progra m path or to verify compliance with a sp ecific req uirement o r defect r emediation . | |
45 | ||
46 | Field | |
47 | Descriptio n | |
48 | Test Case ID: | |
49 | CAS_RxSU2_ TC_001 | |
50 | RTC ID: | |
51 | ||
52 | RM ID: | |
53 | ||
54 | QM ID: | |
55 | ||
56 | Tester: | |
57 | Samuel Gut ema | |
58 | Environmen t: | |
59 | CHYSHR, DA YTSHR, CPR S | |
60 | Build : | |
61 | ||
62 | Use Case N ame: | |
63 | Accept Non -VA Medica tion with complex si g | |
64 | Scenario: | |
65 | As a clini cian enter ing non-VA medicatio ns, user n eed the op tion to us e the “Com plex” SIG functional ity (avail able for o utpatient medication s), so tha t I can ca pture vari ations in medication schedules | |
66 | ||
67 | Actors: | |
68 | Pharmacist | |
69 | Pre-Condit ion: | |
70 | The Pharma cist must have an ac tive VistA account w ith access to the On eVA Pharma cy Program . | |
71 | ||
72 | ||
73 | Post-Condi tion | |
74 | Complex sc hedule tab enabled f or non-VA medication s | |
75 | ||
76 | ||
77 | ||
78 | ||
79 | ||
80 | ||
81 | St | |
82 | Actions an d Expected Results | |
83 | Pass | |
84 | Fail | |
85 | ||
86 | Actions | |
87 | ||
88 | ||
89 | ||
90 | Log into C PRS | |
91 | ||
92 | ||
93 | ||
94 | Expected R esults | |
95 | ||
96 | ||
97 | ||
98 | ||
99 | ||
100 | ||
101 | ||
102 | ||
103 | ||
104 | ||
105 | ||
106 | ||
107 | ||
108 | ||
109 | ||
110 | ||
111 | ||
112 | ||
113 | ||
114 | ||
115 | ||
116 | ||
117 | ||
118 | ||
119 | ||
120 | ||
121 | ||
122 | Actions | |
123 | ||
124 | ||
125 | ||
126 | ||
127 | Select Med s Non-Va | |
128 | ||
129 | ||
130 | ||
131 | Expected R esults | |
132 | ||
133 | ||
134 | ||
135 | ||
136 | ||
137 | ||
138 | ||
139 | ||
140 | ||
141 | ||
142 | ||
143 | ||
144 | ||
145 | ||
146 | ||
147 | ||
148 | ||
149 | ||
150 | ||
151 | ||
152 | ||
153 | ||
154 | ||
155 | ||
156 | Actions | |
157 | ||
158 | ||
159 | ||
160 | ||
161 | ||
162 | ||
163 | Select a D rug | |
164 | ||
165 | ||
166 | ||
167 | Expected R esults | |
168 | ||
169 | ||
170 | ||
171 | ||
172 | ||
173 | ||
174 | ||
175 | ||
176 | ||
177 | ||
178 | ||
179 | ||
180 | ||
181 | ||
182 | ||
183 | ||
184 | ||
185 | ||
186 | ||
187 | ||
188 | Actions | |
189 | ||
190 | ||
191 | ||
192 | Choose Com plex Tab | |
193 | ||
194 | ||
195 | ||
196 | Expected R esults | |
197 | ||
198 | ||
199 | ||
200 | ||
201 | ||
202 | ||
203 | ||
204 | ||
205 | ||
206 | ||
207 | ||
208 | ||
209 | ||
210 | . | |
211 | ||
212 | ||
213 | ||
214 | Actions | |
215 | ||
216 | ||
217 | ||
218 | Complete a ll the inf o on at le ast 2 line s to creat e the comp lex order, then clic k “accept order” | |
219 | ||
220 | ||
221 | ||
222 | Expected R esults | |
223 | ||
224 | ||
225 | ||
226 | ||
227 | ||
228 | ||
229 | ||
230 | ||
231 | ||
232 | ||
233 | ||
234 | ||
235 | ||
236 | ||
237 | ||
238 | ||
239 | ||
240 | Actions | |
241 | ||
242 | ||
243 | ||
244 | Click on Q uit | |
245 | ||
246 | ||
247 | ||
248 | Expected R esults | |
249 | ||
250 | ||
251 | ||
252 | ||
253 | ||
254 | ||
255 | ||
256 | ||
257 | ||
258 | ||
259 | ||
260 | ||
261 | ||
262 | ||
263 | Actions | |
264 | ||
265 | ||
266 | ||
267 | ||
268 | ||
269 | Right Clic k on the B old order (order jus t created) and selec t SIGN | |
270 | ||
271 | ||
272 | ||
273 | Expected R esults | |
274 | ||
275 | ||
276 | ||
277 | ||
278 | ||
279 | ||
280 | ||
281 | ||
282 | ||
283 | ||
284 | ||
285 | ||
286 | ||
287 | ||
288 | ||
289 | ||
290 | Actions | |
291 | ||
292 | ||
293 | Select Sig n returns you to Ord ers screen | |
294 | ||
295 | ||
296 | Expected R esults | |
297 | ||
298 | ||
299 | ||
300 | ||
301 | 9. | |
302 | Actions | |
303 | ||
304 | ||
305 | Select Med s Tab and scroll dow n to order just plac ed under N on-VA Medi cations | |
306 | ||
307 | ||
308 | Expected R esults | |
309 | ||
310 | ||
311 | ||
312 | ||
313 | 10. | |
314 | Actions | |
315 | ||
316 | ||
317 | Double cli ck on the order to d isplay Det ails and v erify all match | |
318 | ||
319 | ||
320 | Expected R esults | |
321 | ||
322 | ||
323 | ||
324 | ||
325 | ||
326 | ||
327 | Acronyms & Abbreviat ions | |
328 | Acronym | |
329 | Definition | |
330 | CAS | |
331 | Clinical A ncillary S ervices | |
332 | CHYSHR | |
333 | Test Envir onment fo r Host sit e | |
334 | CPRS | |
335 | Computeriz ed Patient Record Sy stem | |
336 | DAYTSHR | |
337 | Test Envir onment fo r the disp ensing sit e (remote) | |
338 | VHA | |
339 | Veteran’s Health Adm inistratio n | |
340 | VistA | |
341 | Veterans H ealth Info rmation Sy stems and Technology Architect ure |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.